[Jed]: So a couple of years ago, I went to a small number of supplement companies and
said, "Help," and challenged them to take the supplements that they were making that
we had tested and verified contained what they said they had and to offer to supply
them for clinical trials that we were approached about partnering on.
And not only to supply the material free of charge, but to supply all the documentation
and paperwork that would go along with an application to an institutional review board
or to the FDA, in fact, for an investigational new drug application for permission to work
on that disease with that compound.
And a few companies did come forward.
One of them was called Nutramax and they have a product called Avmacol, which they sort
of took a page from our playbook and they made something with glucoraphanin and myrosinase.
And so that's actually been used in a number, quite a large number of clinical trials now.
And so I don't think...
We've tested it in people, of course.
I don't think there's anything ready to be published yet, but those publications will
be coming along very shortly.
[Rhonda]: And that actually does contain the glucoraphanin and myrosinase and you've validated
that?
[Jed]: Yes, we would certainly not recommend something to anybody without checking it.
And we've checked every batch that they've put on the market because we don't want to
be in a position...
I don't want to have egg on my face, and have recommended to a friend that this is a product
worth using and then have it turn out to be a dud.
[Rhonda]: So you mentioned the sulforaphane one, which is the Prostaphane, the Avmacol,
which has the glucoraphanin plus the myrosinase, and then there's the one that just has glucoraphanin.
I think you mentioned it was by Thorne?
[Jed]: They're one of a number of companies that have a decent...I shouldn't say that
have a decent one.
They're probably if you put this on a webinar, there are probably going to be 10 companies
that say, "We have a decent one, too."
I'm sure there are others, but we've tested...
[Rhonda]: You've tested, and that's important.
[Jed]: Yes, we've tested a product by Thorne, which is a medium or a large-size supplement
maker, and their product is called Crucera-SGS.
[Rhonda]: But that only has glucoraphanin in it?
[Jed]: Right.
[Rhonda]: And this actually brings me back to...I kinda want to get back to this and
that is the microbiome.
And so if you're taking a supplement that only has glucoraphanin and does not have the
myrosinase enzyme there, then you're relying on what you possibly potentially have in a
species of bacteria in the gut, which maybe you can illuminate what that species of bacteria
is, or if there's ways we can increase it, probiotics.
Obviously, wiping out the gut bacteria.
So people with chronic antibiotic use may not be able to convert glucoraphanin very
well, the sulforaphane, I would presume.
[Jed]: Right.
You must have read one of our papers.
So in fact, we did show that, this was a number of years ago now, we showed that if volunteers
took a Fleet enema, self-administered enema, which reduces the number of bacteria, certainly
in their large intestine, by, I don't know, five or six orders of magnitude, and took
a preoperative antibiotic course, in other words, something that one would take prior
to having intestinal surgery, they essentially wiped out most of the bacteria in their intestines.
And those people went from whatever their level of conversion of glucoraphanin to sulforaphane
and its metabolites was, which was, as you heard earlier, was 10% to 70% to nothing.
So they lost their ability to convert glucoraphanin to sulforaphane.
And then over the course of a couple of weeks, I think, as I recall, we followed them, one
or two subsequent challenges with glucoraphanin two weeks and four weeks later, I think.
They gradually regained their ability to do that reaction.
Clearly residual bacteria or new colonizers in their guts had myrosinase activity.
So we've looked at hundreds and hundreds of people's ability to do this conversion and
nobody can't do it.
So everybody that's living and breathing appears to have myrosinase-producing bacteria in their
gut.
But as we said earlier, obviously, it's at very different levels.
Just as clearly, although we don't do bacterial sequencing here, and this is a new and very
exciting field of the microbiome, but it's very clear that there certain strains or certain
species of bacteria that do have myrosinase activity.
Others have shown that there are, I believe one of them is enterococcus, there are lactobacilli
that have myrosinase activity.
There are Bifidobacterium, I believe, that have it.
And again, this is not my field of expertise, so I may have misspoken.
But the bottom line is that there are a number of species of bacteria that do this, but certainly
not all bacteria in your gut.
This whole, incredibly fascinating field of the microbiome has certainly shown that each
of us has different populations and different ratios of different types of bacteria in our
guts.
And certainly, to the degree that this is true, that's going to affect the amount of
myrosinase activity in our guts.
I can tell you that we have done, we haven't published this, but we've done studies with
mice in which we've challenged them with glucoraphanin on a regular basis over time.
And the goal was to try to push them by natural selection, to try to push them to have more
bacteria with more myrosinase activity.
The fact that we haven't published it means we didn't move the needle well enough or reproducibly
enough to have a good story to tell, but certainly that's we believe might happen.
Having said that, we look at real people and we query them as to their habits.
There is no evidence to date that people who say they eat a pound of broccoli a day, that's
a little bit of an exaggeration, but people who eat a lot of broccoli don't necessary
convert glucoraphanin better than people who don't eat much at all.
So that speaks to some other selective pressure on the gut on myrosinase-containing bacteria.
[Rhonda]: Yeah.
I would think that even just eating a healthy meal in general when you're eating a diet
high in vegetables and fermentable fibers and things that are growing Bifidobacteria
and lactobacillus and all these species of bacteria that are commensal bacteria, that
even that itself would potentially then increase your chances of being able to have more myrosinase
because you're having more of this commensal microbiome, but I guess we don't know.
[Jed]: You know, we don't know.
I think both of our hunches are correct.
But the proof is in the pudding.
This whole issue of probiotics...
[Rhonda]: Yes.
That was going to be my next question.
That would be interesting to view.
[Jed]: Well, it's fascinating.
You know, in Europe, there is a lot, I think the regulatory climate in Europe for probiotics
is a bit more receptive than in the U.S.
You probably know more about it than I do.
But I know that the use of probiotics seems to be increasing in the U.S., and studies
by those who are expert in the field of probiotics are mixed.
[Rhonda]: Well, it's the same case as the glucoraphanin sulforaphane supplements.
A lot of the probiotics in the market, there is a lot of dead bacteria in them...
[Jed]: A lot of garbage, yeah.
[Rhonda]: ...a lot of garbage.
I mean, this is ubiquitous in all supplement.
You know, I think there was even a study showing something like 70% of, like, a lot of these
supplements on the market are not actually what they say they are, they don't have the
concentrations they say.
But, yeah, I think that there is a lot of mixed data and that comes down to not having
quality probiotics and also the numbers.
That's another problem, too low numbers of.... [Jed]: Right, 10 billion per...
[Rhonda]: Yeah, that's nothing.
You know, it's like a drop in the pool.
It's not going to even move the needle.
But there is a probiotic out there that I've seen at least two dozen publications including
clinical trials in humans and then there's more mechanistic studies in animals using
VSL number three.
It's called, they're sachets and they have 450 billion probiotics per sachet and they
have a mixture of lactobacillus and Bifidobacterium and some other ones but showing efficacy in
treating IBS, Crohn's.
You know, so I think you can find quality probiotics, but it's just, again, it's the
same thing that you've seen in your field, is finding the right one.
[Jed]: Absolutely.
I think the issue of the numbers of cells, I mean, to a non-scientist consumer, "billions"
sounds like a huge number.
Well, yeah, it is, but it's still...you know, you can fit a billion bacteria on a pin, probably,
well, maybe a teaspoon.
Anyway, the issue there, though, is a lot of the issue is survival.
So if you boast about having billions of bacterial cells of a certain type in yogurt, for example,
and you're not on proton pump inhibitors, so you have an acid stomach and you send that
yogurt through your stomach, how many of those bacteria actually make it through the acid
environment of the stomach?
So, I mean, people have studied that certainly, but there are studies, as you say, with a
small number of specific strains showing effects.
I think some of the more striking effects have to do with childhood diarrhea and there
are even studies showing effects on asthma.
[Rhonda]: Effects on the brain.
It's incredible.
[Jed]: Yeah.
So I'm absolutely a believer that what's goes on in the gut matters to the rest of the body.
There is no question about it.
I think, as you say, a lot of the studies suffer from the fact that what's being given
probably couldn't have been expected to be efficacious anyway because it just died or
didn't get there.
But speaking of probiotics, wouldn't it be cool if someone came up with a myrosinase
containing strain and put it in a probiotic formulation so that you could take that along
with your cruciferous vegetables?
[Rhonda]: So cool.
[Jed]: I believe that there are companies that are working on that now because certainly,
it's well enough known what strains of bacteria have myrosinase activity.
There may be issues of getting that activity maintained when you grow up vats full of bacteria
to freeze-dry them, to put them in a formulation.
But I hope it's only a matter of time before we see formulations that contain myrosinase
and that are safe.
I mean, obviously, safety of these probiotic formulations is something that is a concern
to the regulators and it should be.
So we'll see.
I don't think we're quite there, but I hope we are getting there.